These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22306904)

  • 1. Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.
    Ghazi A; Ashoori A; Hanley PJ; Brawley VS; Shaffer DR; Kew Y; Powell SZ; Grossman R; Grada Z; Scheurer ME; Hegde M; Leen AM; Bollard CM; Rooney CM; Heslop HE; Gottschalk S; Ahmed N
    J Immunother; 2012; 35(2):159-68. PubMed ID: 22306904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The detection of CMV pp65 and IE1 in glioblastoma multiforme.
    Lucas KG; Bao L; Bruggeman R; Dunham K; Specht C
    J Neurooncol; 2011 Jun; 103(2):231-8. PubMed ID: 20820869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.
    Reap EA; Suryadevara CM; Batich KA; Sanchez-Perez L; Archer GE; Schmittling RJ; Norberg PK; Herndon JE; Healy P; Congdon KL; Gedeon PC; Campbell OC; Swartz AM; Riccione KA; Yi JS; Hossain-Ibrahim MK; Saraswathula A; Nair SK; Dunn-Pirio AM; Broome TM; Weinhold KJ; Desjardins A; Vlahovic G; McLendon RE; Friedman AH; Friedman HS; Bigner DD; Fecci PE; Mitchell DA; Sampson JH
    Cancer Res; 2018 Jan; 78(1):256-264. PubMed ID: 29093005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.
    Nair SK; De Leon G; Boczkowski D; Schmittling R; Xie W; Staats J; Liu R; Johnson LA; Weinhold K; Archer GE; Sampson JH; Mitchell DA
    Clin Cancer Res; 2014 May; 20(10):2684-94. PubMed ID: 24658154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
    Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
    Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
    Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F
    J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.
    Wakefield A; Pignata A; Ghazi A; Ashoori A; Hegde M; Landi D; Gray T; Scheurer ME; Chintagumpala M; Adesina A; Gottschalk S; Hicks J; Powell SZ; Ahmed N
    J Neurooncol; 2015 Nov; 125(2):307-15. PubMed ID: 26341370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial.
    Weathers SP; Penas-Prado M; Pei BL; Ling X; Kassab C; Banerjee P; Bdiwi M; Shaim H; Alsuliman A; Shanley M; de Groot JF; O'Brien BJ; Harrison R; Majd N; Kamiya-Matsuoka C; Fuller GN; Huse JT; Chi L; Rao G; Weinberg JS; Lang FF; Sawaya R; Shpall EJ; Rezvani K; Heimberger AB
    Clin Cancer Res; 2020 Jul; 26(14):3565-3577. PubMed ID: 32299815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IE1-pp65 recombinant protein from human CMV combined with a nanoparticulate carrier, SMBV, as a potential source for the development of anti-human CMV adoptive immunotherapy.
    Vaz-Santiago J; Lulé J; Rohrlich P; Kravtzoff R; Le Roy E; Davignon JL; Betbeder D; Davrinche C
    Cytotherapy; 2002; 4(1):11-9. PubMed ID: 11953037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme.
    Crough T; Beagley L; Smith C; Jones L; Walker DG; Khanna R
    Immunol Cell Biol; 2012 Oct; 90(9):872-80. PubMed ID: 22508289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma.
    Schuessler A; Smith C; Beagley L; Boyle GM; Rehan S; Matthews K; Jones L; Crough T; Dasari V; Klein K; Smalley A; Alexander H; Walker DG; Khanna R
    Cancer Res; 2014 Jul; 74(13):3466-76. PubMed ID: 24795429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
    Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
    J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.
    Knight A; Arnouk H; Britt W; Gillespie GY; Cloud GA; Harkins L; Su Y; Lowdell MW; Lamb LS
    PLoS One; 2013; 8(8):e68729. PubMed ID: 23950874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term glioblastoma survival following recovery from cytomegalovirus colitis: A case report.
    Lamano JB; Quaggin-Smith JA; Horbinski CM; Tate MC; Grimm SA; Kumthekar PU; Bloch O
    J Clin Neurosci; 2019 Jun; 64():18-21. PubMed ID: 30948314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease.
    Hobeika A; Osada T; Serra D; Peplinski S; Hanson K; Tanaka Y; Niedzwiecki D; Chao N; Rizzieri D; Lyerly H; Clay T; Morse M
    Cytotherapy; 2008; 10(3):289-302. PubMed ID: 18418774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid generation of CMV pp65-specific T cells for immunotherapy.
    Bao L; Sun Q; Lucas KG
    J Immunother; 2007; 30(5):557-61. PubMed ID: 17589296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.
    Dziurzynski K; Wei J; Qiao W; Hatiboglu MA; Kong LY; Wu A; Wang Y; Cahill D; Levine N; Prabhu S; Rao G; Sawaya R; Heimberger AB
    Clin Cancer Res; 2011 Jul; 17(14):4642-9. PubMed ID: 21490182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65.
    Sun Q; Pollok KE; Burton RL; Dai LJ; Britt W; Emanuel DJ; Lucas KG
    Blood; 1999 Nov; 94(9):3242-50. PubMed ID: 10556213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
    Scherrenburg J; Schellens IM; van Baarle D
    Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.